No effect of diltiazem on the hepatic clearance of indocyanine green in the rats

Archives of Pharmacal Research

Volumn 21, Issue 4, 1998, Pages 411-417

  Joo, Eun Hee ^a   Lee, Yong Bok ^a  

^a Chonnam National University   (South Korea)

Author keywords

Diltiazem; Indocyanine green; Steady state hepatic blood clearance

Indexed keywords

COLORING AGENT; DILTIAZEM; INDOCYANINE GREEN; PLASMA PROTEIN;

ANIMAL; ARTICLE; DOSE RESPONSE; DRUG EFFECT; LIVER FUNCTION TEST; MALE; METABOLIC CLEARANCE RATE; METABOLISM; PROTEIN BINDING; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; BLOOD PROTEINS; COLORING AGENTS; DILTIAZEM; DOSE-RESPONSE RELATIONSHIP, DRUG; INDOCYANINE GREEN; LIVER FUNCTION TESTS; MALE; METABOLIC CLEARANCE RATE; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0032129845     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02974635     Document Type: Article

References (35)

1. Antman, E. M., Stone, P. H., Müller, J. E. and Braunwald, E., Calcium channel blocking agents in the treatment of cardiovascular disorders. Part 1: Basic and clinical electrophysiologic effects. Ann. Intern. Mod., 93, 875-885 (1980).
2. 1-lipoproteins. Proc. Soc. Exp. Biol. Med., 122, 957-963 (1966).
3. Bauer, L. A., Stenwall, M., Horn, J. R., Davis, R., Opheim, K. and Greene, L., Changes in antipyrine and indocyanine green kinetics during nifedipine, verapamil, and diltiazem therapy. J. Clin. Pharmacol., 40, 239-242 (1986).
4. Bourassa, M. G., Cote, P., Theroux, P., Tubau, J. F., Genain, C. and Waters, D. D., Hemodynamics and coronary flow following diltiazem administration in anesthetized dogs and in humans. Chest, 78, 224-230 (1980)
5. Caesar, J., Shaldon, S., Chiandussi, L., Guevara, L. and Sherlock, S., The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function. Clin. Sci. 21, 43-57 (1961).
6. Chaffman, M. and Brogden, R. N., Diltiazem: A review of its pharmacological properties and therapeutic efficacy. Drugs, 29, 387-454 (1985).
7. Daemen, M. J. A. P., Thijssen, H. H. W., van Essen, H., Vervoort-Peters, H. T. M., Prinzen, F. W., Struyker, H. A. J. and Smits, J. F. M., Liver blood flow measurement in the rat. J. Pharmacol. Meth., 21, 287-297 (1989).
8. Daneshmend, T. K., Jackson, L. and Roberts, C. J. C., Physiological and pharmacological variability in estimated hepatic blood flow in man. Br. J. Clin. Pharmacol. 11, 491-496 (1981).
9. Dorr, M. B. and Pollack, G. M., Specific assay for the quantitation of indocyanine green in rat plasma using high performance liquid chromatography with fluorescence detection. J. Pharm. Sci., 78, 828-833 (1989).
10. Flaim, S. F. and Zelis, R., Regional distribution of cardiac output in conscious rats at rest and during exercise: Effects of diltiazem. Chest, 78, 187S-192S (1980).
11. Flaim, S. F. and Zelis, R., Effects of diltiazem on total cardiac output distribution in conscious rats. J. Pharm. Exp. Ther., 222, 359-366 (1982).
12. Freely, J., Nifedipine increases and glyceryl trinitrate decreases apparent liver blood flow in normal subjects. Br. J. Clin. Pharmacol., 17, 83-85 (1984).
13. Gibaldi, M. and Perrier, D., Pharmacokinetics, Marcel Dekker, New York, 1982.
14. Goebel, K. J. and Kolle, E. U., High performance liquid chromatographic determination of diltiazem and four of its metabolites in plasma. J Chromatogr. 345, 355-363 (1985).
15. Grainger, S. L., Keeling, P. W. N., Brown, I. M. H., Marigold, J. H. and Thompson, R. P. H., Clearance and noninvasive determination of the hepatic extraction of indocyanine green in baboons and man. Clin. Sci., 64, 207-212 (1983)
16. Isanta, J. R., Lasheras, B., Fos, D. and Cenarruzabeitia, E., Comparative diltiazem plasma clearance in normotensive and hypertensive rats. J. Pharm. Sci., 76, 862-865 (1987).
17. Klaassen, C. D. and Plaa, G. L., Plasma disappearance and biliary excretion of indocyanine green in rats, rabbits and dogs. Toxicol. Appl. Pharmacol., 15, 374-384 (1969).
18. Kraft, W., Lechner, J., Vollmar, A. M., Reusch, C., Warmbier, M. and Lohss, E., Indozyaningruntest beim Hund. Tierärztl. Prax., 19, 439-446 (1991).
19. Lee, Y. B., Koh, I. B. and Lee, M. H., The effect of phenobarbital pretreatment on the pharmacokinetics of diltiazem in rats. J. Kor. Pharm. Sci., 22, 219-227 (1992)
20. Lee, Y. B., Pharmacokinetic analysis of the effect of phenobarbital on the hepatic transport of indocyanine green. Ph. D. Thesis, Seoul National University, Seoul, Korea (1993)
21. McDevitt, D. G., Nies, A. S. and Wilkinson, G. R., Influence of phenobarbital on factors responsible for hepatic clearance of indocyanine green in the rat. Biochem. Pharmacol., 26, 1247-1250 (1977).
22. Meredith, P. A., Elliott, H. L., Pasanisi, F., Kelman, A. W., Sumner, D. J. and Reid, J. L., Verapamil pharmacokinetics and apparent hepatic and renal blood flow. Br. J. Clin. Pharmacol., 20, 101-106, (1985).
23. Nagao, T., Narita, H., Sato, M. Nakajima, H. and Kiyomoto, A., Development of diltiazem, a calcium antagonist: Coronary vasodilating and hypotensive actions. Clin. Exp. Hyperten. A4, 285-296 (1982).
24. Narita, H., Nagao, T. Yabana, H. and Yamaguchi, I., Hypotensive and diuretic actions of diltiazem in spontaneously hypertensive and Wistar Kyoto rats. J. Pharmacol. Exp. Ther., 227, 472-477 (1983).
25. Pang, K. S. and Rowland, M., Hepatic clearance of drugs. I. Theoretical considerations of a "well-stirred" model and a "parallel tube" model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance. J. Pharmacokinet. Biopharm., 5, 625-653 (1977).
26. Paumgartner, G., Probst, P., Kraines, R. and Leevy, C. M., Kinetics of indocyanine green removal from the blood. Ann. N. Y. Acad Sci., 170, 134-147 (1970).
27. Pollack, G. M. and Brouwer, K. L. R., Thermal injury decreases hepatic blood flow and the intrinsic clearance of indocyanine green in the rat. Pharm. Res., 8, 106-111 (1991).
28. Pollack, G. M., Brouwer, K. L. R., Demby, K. B. and Jones, J. A., Determination of hepatic blood flow in the rat using sequential infusions of indocyanine green or galactose. Drug Met. Disposit., 18, 197-202 (1990).
29. 2-receptor antagonists on steady-state extraction of indocyanine green and lidocaine by the perfused rat liver. J. Lab. Clin. Med., 107, 112-117 (1986).
30. Sato, M., Nagao, T., Yamaguchi, I., Nakajima, H. and Kiyomoto, A., Pharmacological studies on a new 1, 5-benzothiazepine derivative (CRD-401). Arzneim.-Forsch., 21, 1338-1343 (1971).
31. Skak, C. and Keiding, S., Methodological problems in the use of indocyanine green to estimate hepatic blood flow and ICG clearance in man. Liver, 7, 155-162 (1987).
32. Skerjanec, A., O'Brien, D. W. and Tam, Y. K., Hepatic blood flow measurements and indocyanine green kinetics in a chronic dog model. Pharm. Res., 11, 1511-1515 (1994).
33. Stone, P. H., Antman, E. M., Muller, J. E. and Braunwald, E., Calcium channel blocking agents in the treatment of cardiovascular disorders. Part II. Hemodynamic effects and clinical applications. Ann. Intern. Med. 93, 866-904 (1980).
34. Tozer, T. N., Gambertoglio, J. G., Furst, D. E., Avery, D. S. and Holford, N. H. G., Volume shifts and protein binding estimates using equilibrium dialysis. Application to prednisolone binding in humans. J. Pharm. Sci., 72, 1442 (1983).
35. Zelis, R. and Schroeder, J. S., Symposium on calcium, calcium antagonists, and cardiovascular disease. Chest, 78, 121-247 (1980).